New Options for In-Line Particle Size Analysis of Pharmaceuticals from Malvern

Two new options for the Parsum IPP-70 in-line particle size measurement probe, supplied by Malvern Panalytical, are designed to simplify regulatory compliance for pharmaceutical applications. Full details will be available at the Malvern Panalytical booth (#1205) at this year’s Interphex event in Philadelphia, where the company will also present the Insitec Pharma Voyager system for mobile on-line particle size analysis, the industry leading Mastersizer 2000 and the SyNIRgi near infrared chemical imaging (NIR-CI) system.

The Parsum IPP-70 provides real-time particle size analysis, and is used in pharmaceutical manufacturing to monitor and control granulation, coating and spray drying processes. The first of the new Options allows for the provision of Installation/Operational Qualification (IQ/OQ) documentation together with a verification kit for checking measurement accuracy. In addition the second offers a unit with highly polished contact surfaces, and includes material traceability documentation.

The Parsum IPP-70 delivers size and velocity measurement for particles, granules and pellets from 50 to 6000 microns in diameter. Light and compact, it can be used to monitor gravity fed, pneumatically conveyed and fluidized streams. It is inserted directly into a process line or unit, and is easily integrated with existing systems for automated control. An intrinsically safe version is also available (IPP-70-SE).

The verification kit supplied with Option 1, when used with new software (version 7.1), allows calibration of the whole measurement system – both probe and measurement PC. Calibration is achieved by measuring the diameter of three pins, of certified dimension, mounted on a rotating disc. Option 2 is particularly suitable for fouling duties and/or applications requiring high levels of hygiene.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2019, February 10). New Options for In-Line Particle Size Analysis of Pharmaceuticals from Malvern. AZoM. Retrieved on March 03, 2024 from https://www.azom.com/news.aspx?newsID=10981.

  • MLA

    Malvern Panalytical. "New Options for In-Line Particle Size Analysis of Pharmaceuticals from Malvern". AZoM. 03 March 2024. <https://www.azom.com/news.aspx?newsID=10981>.

  • Chicago

    Malvern Panalytical. "New Options for In-Line Particle Size Analysis of Pharmaceuticals from Malvern". AZoM. https://www.azom.com/news.aspx?newsID=10981. (accessed March 03, 2024).

  • Harvard

    Malvern Panalytical. 2019. New Options for In-Line Particle Size Analysis of Pharmaceuticals from Malvern. AZoM, viewed 03 March 2024, https://www.azom.com/news.aspx?newsID=10981.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.